Downstaging of Carcinoma Cervix

What is Downstaging?

Rationale

• Radical surgery (Wertheim's radical hysterectomy + bilateral pelvic lymphadenectomy) is the definitive treatment for early stages (FIGO IB1, IIA1), offering excellent survival.
• Patients with FIGO stage IB2, IIA2, IIB, and beyond are typically considered inoperable or at high risk for positive margins and nodal involvement.
• Neoadjuvant treatment (NACT) aims to:
  • Shrink tumor volume
  • Eliminate micrometastases
  • Improve surgical resectability and margins
  • Reduce the need for postoperative adjuvant therapy

Indications for Downstaging (Neoadjuvant Treatment)

Agents Used for Neoadjuvant Chemotherapy (NACT)

• BIP regimen - Bleomycin + Ifosfamide + Cisplatin (historically popular in India)
• BVP - Bleomycin + Vincristine + Cisplatin
• Paclitaxel + Cisplatin - modern preferred regimen
• Cisplatin + Irinotecan
• Cisplatin + 5-FU

Criteria for Assessing Response (Prior to Surgery)

• Complete response (CR) - no visible tumor
• Partial response (PR) - >30% reduction in tumor diameter (RECIST criteria)
• Stable disease (SD) - <30% reduction
• Progressive disease (PD) - tumor grows despite treatment

Definitive Surgery After Downstaging

• Wertheim's radical hysterectomy (Type III/Piver III) with bilateral pelvic lymphadenectomy is the standard procedure.
• Performed 3-4 weeks after the last cycle of NACT to allow recovery.
• Pathological evaluation of the specimen determines need for adjuvant therapy.

• Positive pelvic lymph nodes
• Positive parametrial margins
• Positive vaginal margins (confirmed by GOG trials - cisplatin + 5-FU + radiation improves PFS and OS, with 4-year survival 81% vs 71% for radiation alone)

Concurrent Chemoradiation as Downstaging Alternative

• Cisplatin 40 mg/m² weekly + pelvic external beam radiation is the standard.
• Established by 5 GOG randomized trials as superior to radiation alone for stages IIB-IVA (GOG protocols 85, 120, 123).
• Tumor response can render initially unresectable tumors operable or significantly reduce disease burden before brachytherapy.
• Berek & Novak's Gynecology notes: "Radiation therapy fails to achieve tumor control in 20-65% of patients with advanced cervical cancer" - CCRT significantly improves on this.

Outcomes and Evidence

• NACT + surgery had similar oncological outcomes to surgery alone overall, but reduced surgical risk in bulky disease.
• Benefits most pronounced in stage IB2-IIB: improved resection rates, reduced parametrial involvement.
• Cisplatin-based regimens are superior; adenocarcinoma histology tends to respond poorly.

Summary Algorithm

Ca Cervix Diagnosed
        |
    FIGO Staging
        |
   IB1 / IIA1 ──────────────────► Radical surgery directly
        |
  IB2 / IIA2 / IIB
        |
   NACT (2-3 cycles cisplatin-based)
        |
   Response assessment (MRI)
      /        \
Responder    Non-responder
   |               |
Radical        Concurrent
Surgery     chemoradiation
(+ adjuvant   (definitive)
if high-risk)

Key Points for Exams

1. Downstaging is most relevant for FIGO IB2 to IIB disease.
2. Cisplatin-based NACT (2-3 cycles) is standard; BIP, BVP, paclitaxel+cisplatin are common regimens.
3. Surgery is offered only to responders; non-responders get concurrent chemoradiation.
4. Wertheim's radical hysterectomy is the procedure after successful downstaging.
5. Concurrent chemoradiation (weekly cisplatin + EBRT) is the gold standard for unresectable advanced disease (IIB-IVA), established by multiple GOG trials.
6. Post-operative adjuvant CCRT is given for high-risk features (positive nodes, margins, parametria).

• Berek & Novak's Gynecology, pp. 2259-2260

MS OBG Delhi University - 25-Day Theory Exam Prep Plan

Exam Structure (Delhi University)

• Paper I - Applied Basic Sciences
• Paper II - Obstetrics (incl. social obstetrics & diseases of newborn)
• Paper III - Gynaecology
• Paper IV - Recent Advances in OBG

• Q1: Long answer (20 marks)
• Q2: Two parts, 15 marks each (answer in detail)
• Q3: Five short notes, 10 marks each
• All questions compulsory, no choice

The 25-Day Master Plan

Phase 1: Days 1-8 (High-yield topics, write answers)

• Pre-eclampsia / eclampsia (management, MgSO4 protocol, Pritchard vs Zuspan)
• APH - placenta previa & abruption
• PPH - causes, management, B-Lynch, uterine artery ligation

• Preterm labour - tocolysis, antenatal corticosteroids
• IUGR - causes, Doppler monitoring, management
• Gestational diabetes - diagnosis (DIPSI/WHO), management
• Obstetric sepsis / puerperal pyrexia

• Ca cervix - FIGO staging, treatment by stage, downstaging (you already know this one!)
• Ca endometrium - staging, type 1 vs type 2, surgical management
• Ovarian tumours - classification, FIGO staging, surgical management, germ cell vs epithelial
• Fibroid uterus - classification, complications, myomectomy vs hysterectomy

• Endometriosis - pathogenesis, staging (AFS), medical + surgical management
• PID - organisms, diagnosis, treatment
• Infertility - causes, evaluation of couple, ART indications
• Ectopic pregnancy - diagnosis (bhCG, TVS), management (medical vs surgical)

Phase 2: Days 9-15 (Remaining syllabus + short notes bank)

• Anatomy of pelvis - pelvic floor muscles, ligaments, ureter course (surgical importance)
• Menstrual cycle - hormonal control, endometrial changes
• Coagulation cascade - relevance to DIC in obstetrics
• Placental physiology - development, functions, transfer mechanisms
• Immunology of pregnancy - tolerance mechanisms
• Pharmacology - MgSO4, oxytocics, tocolytics, GnRH agonists/antagonists, oral contraceptives

• Birth asphyxia - Apgar, NRP protocol
• Jaundice in newborn - physiological vs pathological, Rh incompatibility, exchange transfusion
• IMNCI, essential newborn care
• Maternal mortality - definitions, causes, reduction strategies (JSY, JSSK, PC-PNDT)
• Safe motherhood initiatives, PMSMA, LaQshya

• FIGO 2018 revised staging (cervix, endometrium, ovary)
• Sentinel lymph node biopsy in gynaecological cancers
• Robotic surgery in OBG - indications, advantages
• Fertility-sparing surgery in early gynaecological cancers
• Hysteroscopy advances - STEP-W classification of fibroids
• Non-invasive prenatal testing (NIPT) - cell-free fetal DNA
• Cell-free DNA, cfDNA screening
• Uterine transplantation (awareness level)
• Immunotherapy/targeted therapy in ovarian cancer (PARP inhibitors - olaparib)
• Minimally invasive surgery for stress urinary incontinence (mid-urethral slings)
• PCOS - Rotterdam criteria, pathogenesis, inositol, metabolic management

• Urinary incontinence - classification, urodynamics, management
• Pelvic organ prolapse - classification (POP-Q), surgical options
• Genital fistulae - VVF, RVF - causes, surgical timing

Phase 3: Days 16-22 (Previous years' questions + answer writing practice)

1. Get 5-10 years of past DU MS OBG papers (your department, seniors, or Google "Delhi University MS OBG previous year question papers")
2. Make a frequency list - which long answers and short notes repeat
3. Write timed full answers - for each long answer, write in ~25-30 minutes; for each short note, write in 8-10 minutes
4. Have a senior or colleague review 1-2 answers per day

• Management of severe pre-eclampsia
• Third stage of labour and management of PPH
• Ovarian hyperstimulation syndrome (OHSS)
• Surgical management of Ca cervix / downstaging
• Endometriosis - diagnosis and management
• Antiphospholipid antibody syndrome in pregnancy
• Induction of labour - methods, Bishop score
• Amniotic fluid embolism
• Rh isoimmunization
• PCOS - pathogenesis and management

Phase 4: Days 23-25 (Consolidation and recall)

• Day 23: Rapid revision of short notes bank (5 per day per paper = 20 short notes total)
• Day 24: One full mock paper (3-hour timed sitting) - write all 3 questions
• Day 25 (Day before exam): Only revise headings, diagrams, and key protocols - NO new reading

Answer Writing Strategy (Critical for DU)

1. Definition / Introduction (2-3 lines)
2. Classification / Aetiology
3. Pathophysiology (brief)
4. Clinical features
5. Investigations
6. Management (with drug doses where relevant)
7. Complications / Prognosis
8. Recent advances (1 para - examiners love this)

• Aim for 1 page with a clear heading, 4-5 points, and 1 diagram/table if applicable
• Always end with "recent advances" or a key fact - differentiates you

• Bishop score table, MgSO4 protocol, B-Lynch suture, WHO staging tables, FIGO staging diagrams

Books and Resources

Daily Schedule Template

Key Mindset Points

• You have enough time. 25 days of focused, structured work is sufficient for a well-prepared MS candidate.
• Don't try to read everything - know 30 topics very well rather than 100 topics superficially.
• Writing practice is non-negotiable. Examiners can tell within 2 pages if the candidate writes well.
• Your downstaging of ca cervix question earlier - that level of structured, stage-by-stage knowledge is exactly what scores 18-19/20 in long answers.

MS OBG Delhi University — Revision Plan: July 27 → August 14

The 19 Days at a Glance

Phase 1: July 27 - August 2 — Content Revision (7 days)

Day 1 — July 27: Paper II Obstetrics (High-yield half)

• Pre-eclampsia / eclampsia — MgSO4 (Pritchard + Zuspan), antihypertensives, delivery timing
• PPH — causes (4T), active management of 3rd stage, B-Lynch, uterine artery ligation, obstetric hysterectomy
• APH — placenta previa vs abruption (differentiation table, management)
• DIC in obstetrics — causes, lab findings, management

Day 2 — July 28: Paper II Obstetrics (Second half)

• Preterm labour — tocolysis (nifedipine, atosiban), antenatal corticosteroids (betamethasone protocol)
• IUGR — causes, classification (symmetric/asymmetric), Doppler (umbilical, MCA, ductus venosus), management
• GDM — DIPSI screening, diagnosis, insulin management, obstetric issues
• Rh isoimmunization — Kleihauer-Betke, anti-D prophylaxis, hydrops, exchange transfusion
• Puerperal sepsis / amniotic fluid embolism
• Induction of labour — Bishop score, methods (PGE2, oxytocin, Foley)

Day 3 — July 29: Paper III Gynaecology (Oncology)

• Ca cervix — FIGO 2018 staging, treatment by stage, downstaging (you know this well — just revise quickly)
• Ca endometrium — type 1 vs 2, FIGO staging, surgical staging, adjuvant therapy
• Ca ovary — epithelial vs germ cell vs sex cord, FIGO staging, debulking surgery, CA-125, PARP inhibitors
• GTN — molar pregnancy, choriocarcinoma, FIGO scoring, EMA-CO regimen
• Vulval carcinoma — staging, sentinel LN biopsy

Day 4 — July 30: Paper III Gynaecology (Benign)

• Fibroid uterus — classification (FIGO PALM-COEIN, intramural/submucosal/subserosal), complications, myomectomy vs hysterectomy, medical Rx (GnRH agonist, ulipristal)
• Endometriosis — pathogenesis, AFS staging, medical (GnRH, dienogest, OCP) + surgical Rx, endometrioma
• PCOS — Rotterdam criteria, pathogenesis, medical management (OCP, metformin, clomiphene, letrozole)
• PID — organisms, Fitz-Hugh-Curtis, treatment (CDC regimen)
• Ectopic pregnancy — risk factors, bhCG discrimination zone, methotrexate criteria, surgery

Day 5 — July 31: Paper III Gynaecology (Urogynaecology + Infertility)

• Infertility — causes, evaluation of couple (semen analysis, HSG, laparoscopy), ART (IUI, IVF, ICSI), OHSS
• Urinary incontinence — stress vs urge vs mixed, urodynamics, Burch colposuspension, mid-urethral slings (TVT/TOT)
• Pelvic organ prolapse — POP-Q system, surgical options (Manchester, Fothergill, sacrocolpopexy)
• VVF — causes, timing of repair, surgical approach
• Abnormal uterine bleeding — PALM-COEIN classification, management

Day 6 — August 1: Paper I Applied Basic Sciences

• Anatomy: Pelvic floor muscles + perineal body, ureter course + surgical danger points, blood supply of uterus, lymphatic drainage (uterus, cervix, ovary)
• Physiology: Menstrual cycle (hormonal graph), placental physiology (development, transfer, endocrine functions), fetal circulation
• Pharmacology: MgSO4 (mechanism, toxicity, antidote), oxytocics (oxytocin, ergometrine, misoprostol, carboprost), tocolytics, GnRH agonists/antagonists, OCP mechanisms
• Pathology/Immunology: DIC coagulation cascade, immunology of pregnancy (maternal tolerance), pre-eclampsia pathophysiology (sFlt-1, PIGF)
• Coagulation: Normal values — PT, aPTT, fibrinogen, D-dimer in obstetric emergencies

Day 7 — August 2: Paper IV Recent Advances (split over today + spillover)

• FIGO 2018 revised staging — cervix, endometrium, ovary (key changes from old staging)
• NIPT / cell-free fetal DNA — what it screens, limitations, when to offer
• Sentinel lymph node biopsy in cervical + endometrial cancer — technique, indications
• PARP inhibitors (olaparib, niraparib) — mechanism, use in BRCA-mutated ovarian cancer
• Robotic surgery in OBG — da Vinci system, indications, advantages/limitations
• Fertility-sparing surgery — early cervical cancer (trachelectomy), early endometrial cancer (progesterone + hysteroscopy)
• Hysteroscopy advances — STEP-W fibroid classification, MISTLETOE complications
• Immunotherapy in gynaecological cancers — pembrolizumab (MSI-H endometrial)
• Uterine transplantation — current status, Gothenburg experience
• LaQshya, PMSMA, recent NMC guidelines (for social obstetrics short notes)

Phase 2: August 3 - August 10 — Answer Writing (8 days)

• Morning (1.5 hrs): Write 1 full long answer (20 marks) — timed 25 minutes, then self-review
• Evening (1.5 hrs): Write 4-5 short notes (10 marks each) — 8 min each

Phase 3: August 11 - August 13 — Final Consolidation (3 days)

Day 11 — August 11: Short notes rapid-fire

1. Amniotic fluid embolism
2. Shoulder dystocia — management (HELPERR mnemonic)
3. Cord prolapse
4. Uterine rupture
5. HELLP syndrome
6. Antiphospholipid antibody syndrome
7. Cervical incompetence / cerclage (McDonald's, Shirodkar)
8. GBS prophylaxis in labour
9. Perineal tears — classification, repair
10. Newborn resuscitation (NRP algorithm)
11. VVF — causes and management
12. Stress urinary incontinence
13. Manchester operation
14. Bartholin's cyst / abscess
15. Ovarian torsion
16. Fibroid in pregnancy
17. Molar pregnancy — types, management, follow-up
18. Staging of vulval carcinoma
19. PALM-COEIN classification
20. Fetal surveillance methods — NST, CST, BPP

Day 12 — August 12: Paper I + Paper IV final pass

• Re-read your Day 6 and Day 7 notes only (not the textbook)
• Write out the lymphatic drainage table (uterus → iliac nodes, cervix → obturator/iliac, ovary → para-aortic)
• Write out the pharmacology drug table (oxytocics, tocolytics, doses)
• Revise all FIGO staging tables from memory

Day 13 — August 13 (Day before exam):

• Morning only — no new topics
• Revise your own written answers from Phase 2
• Review key diagrams: B-Lynch, MgSO4 protocol, pelvic lymphatic drainage, FIGO staging flowcharts
• Eat well, sleep by 10 PM

August 14 — Exam Day Morning

• Headings and first lines of your 20 short notes
• The 4-5 protocols you are most likely to write (MgSO4, PPH management, staging tables)
• Nothing new

Daily Time Commitment

One Final Tip

• MgSO4 loading: 4g IV over 15-20 min + 10g IM (Pritchard) or 4g IV + infusion 1g/hr (Zuspan)
• Oxytocin: 10 units IM or 5 units slow IV or 20-40 units in 500 mL drip
• Carboprost: 250 mcg IM every 15 min, max 8 doses